Hospital News and Research

RSS

TGen to host Pediatric Cancer Translational Genomics in Scottsdale

The Translational Genomics Research Institute (TGen) will host Pediatric Cancer Translational Genomics Feb. 6-8 at the Hotel Valley Ho in Scottsdale, bringing together more than 150 leading pediatric cancer researchers, clinicians and foundations to promote the exchange of information and ideas for advancing pediatric cancer research and treatment.

7 Feb 2012

LE strips can rapidly diagnose periprosthetic joint infection

Rothman Institute at Jefferson joint researchers continue to seek better ways to diagnose and subsequently treat periprosthetic joint infection (PJI) in patients following total joint arthroplasty. Their latest research shows leukocyte esterase reagent (LE) strips, common in diagnosing urinary tract infections, can also have a role in rapid diagnosis of PJI.

7 Feb 2012

How 'observation care' status can drive up patients' hospital bills

News outlets report that this kind of status is leading some Medicare beneficiaries to be surprised by the size of hospital bills because, ultimately, the services they received were not classified as inpatient care.

7 Feb 2012

Novel stem-cell technique to enhance bone growth

A research team led by UC Davis Health System scientists has developed a novel technique to enhance bone growth by using a molecule which, when injected into the bloodstream, directs the body's stem cells to travel to the surface of bones.

7 Feb 2012

GOP candidates: Santorum backs 'discredited' stroke claim, he and Gingrich continue attacks on 'Romneycare'

As the GOP presidential hopefuls continue sparring on the campaign trail, The Associated Press takes a look at the "influence game" and tracks how big donors pursue their policy desires. Meanwhile, House Democrats are betting that Medicare will be the issue that wins them control of their chamber.

7 Feb 2012

Whole-genome sequencing helps trace the path of European E. coli outbreak

Using whole-genome sequencing, a team led by researchers from Harvard School of Public Health (HSPH) and the Broad Institute has traced the path of the E. coli outbreak that sickened thousands and killed over 50 people in Germany in summer 2011 and also caused a smaller outbreak in France.

7 Feb 2012

Fogarty Institute's Advanced Endovascular Training Fellowship to begin on July 1

The Fogarty Institute for Innovation announced today that it has launched its Advanced Endovascular Training Fellowship. This unique, year-long clinical training program for postgraduate physicians, which begins July 1, 2012, will provide Fellows with broad exposure to all aspects of endovascular patient care, with an emphasis on interventional training.

7 Feb 2012

Researchers reveal how molecular imaging can solve breast cancer mysteries

In two new studies featured in the February issue of the Journal of Nuclear Medicine, researchers are revealing how molecular imaging can be used to solve mysteries about difficult cases of breast cancer.

7 Feb 2012

New scoring method helps predict functional outcomes in stroke

A new scoring method can help doctors quickly decide which stroke patients will respond well to the clot-busting drug alteplase, according to a study published in the February 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.

7 Feb 2012

Queen's study aims to improve end of life decision making among elderly

At a time when there is tremendous concern about the utilization of technology at the end of life and the costs of technology, the Canadian Institutes of Health Research (CIHR) has funded a multi-center study aimed to improve end of life decision making amongst seriously ill, elderly hospitalized patients. Queen's University is one institution receiving funding for this initiative.

7 Feb 2012

AJRR selects Remedy Informatics to build national hip and knee replacement registry

The American Joint Replacement Registry (AJRR) has selected Remedy Informatics, the leading provider of registries for Life Science, to build a registry to collect data on all primary and revision total joint replacement procedures in the United States. Representatives from AJRR and Remedy Informatics will unveil the new registry at the American Association of Orthopaedic Surgeons (AAOS) Annual Meeting in San Francisco, Feb. 7 – Feb. 11.

7 Feb 2012

FDA clears Neurelis IND to commence NRL-1 clinical trials for acute breakthrough seizures

Neurelis, Inc. today announced that the United States Food and Drug Administration (FDA) has cleared an Investigational New Drug application (IND) to commence clinical trials advancing the development of NRL-1 for the treatment of acute breakthrough seizures.

7 Feb 2012

Researchers derive vessel-forming stem cells from amniotic fluid

Researchers at Rice University and Texas Children's Hospital have turned stem cells from amniotic fluid into cells that form blood vessels. Their success offers hope that such stem cells may be used to grow tissue patches to repair infant hearts.

7 Feb 2012

CRT2012 conference to discuss PCI procedures using CorPath 200 System

Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that Giora Weisz, M.D., Director of Clinical Cardiovascular Research at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Associate Professor of medicine at Columbia University College of Physicians and Surgeons, New York, N.Y. will present his personal experience using the CorPath 200 System as part of the CorPath PRECISE Trial during a scientific presentation "Cath Lab of the Future: Robotics" at the Cardiovascular Research Technologies' annual meeting, CRT2012.

7 Feb 2012

Preliminary results from Remedy Pharmaceuticals' RP-1127 Phase 2 trial on stroke

Each year, over 700,000 people in the United States suffer a stroke. For most, medical science can do very little. Some will die; a number will suffer debilitating aftereffects. Now, preliminary results of a Phase 2 clinical trial using Remedy Pharmaceuticals' new drug, RP-1127, presented at the 2012 International Stroke Conference in New Orleans on February 2, offer hope to many of these patients.

6 Feb 2012

CWRU/Cleveland Clinic consortium to focus on head, neck and spinal injuries

Cleveland Clinic and Case Western Reserve University are joining forces to form the Cleveland Traumatic Neuromechanics Consortium (TNC), which will investigate and develop better protection and treatment strategies for head, neck and spinal injuries related to sports, military service and automobile accidents.

6 Feb 2012

Positive data from Chimerix CMX001 Phase 2 study on CMV disease

Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV) disease in hematopoietic stem cell transplant (HCT) recipients.

6 Feb 2012